Search - tctmd.com

Displaying 181 - 200 of 671

Sort: Relevancy | Date

Presentation JIM 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presenter: Roxana Mehran

February 10, 2017

Presentation JIM 2017

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

Presenter: Giuseppe Tarantini

February 10, 2017

Presentation

Efficacy and Safety of DAPT After Complex PCI

Presenter: Gennaro Giustino

September 01, 2016

Presentation ESC 2016

“Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX

Presenter: Deepak L. Bhatt

August 31, 2016

Presentation ESC 2016

PRAGUE-18 Study: Randomized Comparison Of Ticagrelor Versus Prasugrel In STEMI

Presenter: Zuzana Motovska

August 30, 2016

Presentation ESC 2016

NIPPON Randomized Study: 6 Months vs 18 Months Dual Antiplatelet Treatment For Patients Underwent Bioabsorbable Polymer And Abluminal Coated DES Deployment

Presenter: Masato Nakamura

August 28, 2016

Presentation ESC 2016

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Presenter: Gilles Montalescot

August 28, 2016

Presentation

Impact Of Gender on 2-Year Clinical Outcomes in Patients Treated With 6- or 24-Month DAPT

Presenter: Giuseppe Gargiulo

August 19, 2016

Presentation

Outcomes Among Older Stable Angina Patients Prescribed Beta-Blockers After PCI

Presenter: AA. Motivala

August 17, 2016

Presentation

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Presenter: Abdul-Jawad Altisent

August 16, 2016

Presentation

Use of DAPT and Patient Outcomes in Those Undergoing PCI: The ROCKET AF Trial

Presenter: Matthew W. Sherwood

August 16, 2016

Presentation

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

Presenter: Raffaele Piccolo

August 10, 2016

Presentation

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Presenter: Gregor Fahrni

July 27, 2016

Presentation

Antiplatelet Therapy and Outcomes in Patients Undergoing Surgery After Stenting

Presenter: Roberta Rossini

July 18, 2016

Presentation

The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After PCI: The ADAPT-DES Study

Presenter: Sorin Brener

July 05, 2016

Presentation

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

Presenter: Rahman Shah

June 20, 2016

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

Presentation CCVVC 2016

Top 10 Advances of Interventional Cardiology 2015

Presenter: Samin K Sharma

June 16, 2016

Presentation CCVVC 2016

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

Presenter: Marc P. Bonaca

June 15, 2016

Presentation SOLACI 2016

Como selecionar o tipo de stent e antiplaquetários para cirurgias não cardíacas

Presenter: Miguel A N Rati

June 10, 2016

Advertisement

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

Efficacy and Safety of DAPT After Complex PCI

“Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX

PRAGUE-18 Study: Randomized Comparison Of Ticagrelor Versus Prasugrel In STEMI

NIPPON Randomized Study: 6 Months vs 18 Months Dual Antiplatelet Treatment For Patients Underwent Bioabsorbable Polymer And Abluminal Coated DES Deployment

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Impact Of Gender on 2-Year Clinical Outcomes in Patients Treated With 6- or 24-Month DAPT

Outcomes Among Older Stable Angina Patients Prescribed Beta-Blockers After PCI

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Use of DAPT and Patient Outcomes in Those Undergoing PCI: The ROCKET AF Trial

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Antiplatelet Therapy and Outcomes in Patients Undergoing Surgery After Stenting

The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After PCI: The ADAPT-DES Study

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

Timing of DAPT Interruption and DES Thrombosis

Top 10 Advances of Interventional Cardiology 2015

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

Como selecionar o tipo de stent e antiplaquetários para cirurgias não cardíacas

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content